| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f09aad99c375dbccd6e0f99d75468413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b37751d0e9c1c5002b423bc8ce6b091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a647c911ac897ab11b5bc6ea73ce754 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-201 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate |
2020-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc25db2b9fbf48eca1aa70f1175be95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d870d9491e1ff41d306d9d02abf788b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c47ff97f8033a1838b0764b5a3f778e |
| publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021138514-A1 |
| titleOfInvention |
Method and apparatus for using quantative and qualitative data from medical imaging examinations for precise dosing regimen |
| abstract |
This patent includes a method for utilizing imaging biomarkers to improve pharmacologic dosing strategies. Specifically, biomarker specific CT and MRI examination protocols are disclosed. Dose adjustments based on imaging biomarkers are discussed. Longitudinal analysis of imaging biomarkers is disclosed assess effectiveness of pharmacotherapy and dosing strategies thereof. Finally, manufacturing of a combination pill with day-to-day variations of drug quantities is disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115641961-A |
| priorityDate |
2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |